This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks to Watch: HP, Netflix, Hormel

NEW YORK ( TheStreet) -- Hewlett-Packard (HPQ - Get Report), the computer and printer maker, said fiscal fourth-quarter earnings fell from a year earlier but still topped Wall Street's expectations.

HP said adjusted earnings per share fell 12% from last year to $1.17 per share. Adjusted net revenue for the quarter ended in October dropped 3% to $32.3 billion.

Analysts were expecting profit of $1.13 a share on sales of $32 billion.

Chief Financial Officer Catherine Lesjak said HP was "remaining cautious" about fiscal 2012, and HP forecast non-GAAP earnings of 83 cents a share for its fiscal first quarter ending in January. Wall Street's current consensus view is for a profit of $1.11 a share. For the full year, the Dow component sees non-GAAP earnings of at least $4 per share vs. the average analysts' estimate of $4.54 a share.

In premarket trading Tuesday, HP shares fell 1.8% to $26.37.


Netflix (NFLX - Get Report) is raising an additional $200 million in capital through the sale of zero coupon convertible notes.

Technology Crossover Ventures will be buying the notes, and has the right to nominate one person Netflix's board.

The stock fell 3.7% to $71.75 in premarket trading Tuesday.


Hormel Foods (HRL - Get Report) said fiscal fourth-quarter profit fell 3%.

The maker of Spam said net income fell to $117.3 million, or 43 cents a share, from $121.1 million, or 45 cents, last year.

Analysts were expecting a profit of 42 cents a share.

Sales rose 2% percent to $2.1 billion.

Hormel provided an outlook for 2012 above analysts' expectations.


Brocade Communications (BRCD - Get Report) blew past Wall Street's expectations in its fiscal fourth quarter.

The networking equipment company reported adjusted earnings of $79 million, or 16 cents a share, for the three months ended Oct. 29. Revenue was $550 million, up 9% on a sequential basis but virtually flat from last year. .

Analysts were calling for a profit of 10 cents a share in the latest quarter on revenue of $527.4 million.


Medtronic (MDT - Get Report), the health care technology provider, is expected by analysts Tuesday to report earnings of 82 cents a share on revenue of $4.1 billion.

Last week, Medtronic agreed to sell Physio-Control, an emergency medical response technology group, to private-equity firm Bain Capital for $487 million.


Campbell Soup (CPB - Get Report), the soup maker, is expected by analysts Tuesday to report earnings of 79 cents a share on revenue of $2.2 billion.


Chico's (CHS - Get Report), the women's retailer, is expected by analysts to post third-quarter earnings of 20 cents a share on revenue of $548.5 million. Analysts surveyed by Thomson Reuters expect same-store sales for the quarter to rise mor e than 5%.


Gilead Sciences (GILD - Get Report) agreed on Monday to buy Pharmasset (VRUS) for $11 billion in cash and debt, vaulting Gilead into the lead to develop the next generation of all-oral hepatitis C therapies.

The acquisition price of $137 a share was an 89% premium to Pharmasset's closing price Friday of $72.67.

Pharmasset shares rose 84.6% Monday to close at $134.14.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Related links:


Copyright 2011 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BRCD $10.71 0.00%
CHS $14.88 0.00%
CPB $47.80 0.00%
GILD $107.78 0.00%
HPQ $28.03 0.00%

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs